Testing effectiveness (Phase 2)Study completedNCT01303380What this trial is testingCanakinumab in Patients With Active Hyper-IgD SyndromeWho this might be right forMevalonate Kinase Deficiency Novartis Pharmaceuticals 9
Not applicableWithdrawnNCT01568736What this trial is testingB7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase DeficiencyWho this might be right forHyper IgD SyndromeMevalonate Kinase Deficiency Michigan Technological University
Not applicableEnded earlyNCT00260299What this trial is testingDietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase DeficiencyWho this might be right forMevalonic AciduriaMevalonate Kinase DeficiencyImmune System Diseases+2 more Oregon Health and Science University 1
Large-scale testing (Phase 3)Study completedNCT02334748What this trial is testingCanakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 StudiesWho this might be right forSystemic Juvenile Idiopathic ArthritisHereditary Periodic Fevers Novartis Pharmaceuticals 31
Large-scale testing (Phase 3)Study completedNCT02911857What this trial is testingAn Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever SyndromesWho this might be right forPeriodic Fevers Syndrome Novartis Pharmaceuticals 4
Not applicableLooking for participantsNCT06838143What this trial is testingIlaris NIS in KoreaWho this might be right forHereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)Colchicine Resistance Familial Mediterranean Fever (crFMF)+3 more Novartis Pharmaceuticals 25
Not applicableLooking for participantsNCT06497829What this trial is testingGeranylgeraniol Supplementation in Patients With Mevalonate Kinase DeficiencyWho this might be right forMevalonate Kinase Deficiency University Hospital, Motol 6